FluoroPharma Medical, Inc.
FPMI
$0.0001
$0.000.00%
OTC PK
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 417.60K | 341.50K | 439.70K | 492.30K | 691.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 521.50K | 319.60K | 679.40K | 682.00K | 835.50K |
| Operating Income | -521.50K | -319.60K | -679.40K | -682.00K | -835.50K |
| Income Before Tax | -127.20K | 384.10K | -734.10K | -1.57M | -1.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -127.20K | 384.10K | -734.10K | -1.57M | -1.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -127.20K | 384.10K | -734.10K | -1.57M | -1.27M |
| EBIT | -521.50K | -319.60K | -679.40K | -682.00K | -835.50K |
| EBITDA | -510.60K | -308.60K | -668.30K | -671.00K | -824.40K |
| EPS Basic | -0.01 | 0.01 | -0.03 | -0.05 | -0.04 |
| Normalized Basic EPS | 0.00 | 0.01 | -0.01 | -0.01 | -0.03 |
| EPS Diluted | -0.01 | 0.00 | -0.03 | -0.05 | -0.04 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.03 |
| Average Basic Shares Outstanding | 34.03M | 33.71M | 33.42M | 33.06M | 31.65M |
| Average Diluted Shares Outstanding | 34.03M | 76.24M | 33.42M | 33.06M | 31.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |